FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108852904> ?p ?o ?g. }

• W3108852904 endingPage "e542" @default.
• W3108852904 startingPage "e542" @default.
• W3108852904 abstract "We read Audrey Tran and Vinay Prasad's critique 1 Tran AA Prasad V Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy. Lancet Oncol. 2020; 21: 1134-1136 Summary Full Text Full Text PDF PubMed Scopus (10) Google Scholar of drug repurposing for cancer with disquiet, as we believe that it seriously mischaracterises the concept. The authors' definition of a repurposed drug as “an affordable, widely available medication, often indicated for a common condition”, is idiosyncratic. 1 Tran AA Prasad V Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy. Lancet Oncol. 2020; 21: 1134-1136 Summary Full Text Full Text PDF PubMed Scopus (10) Google Scholar Drug repurposing is best defined as a strategy for identifying new uses for approved drugs, outside the scope of the original indication. 2 Pushpakom S Iorio F Eyers PA et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019; 18: 41-58 Crossref PubMed Scopus (1436) Google Scholar These strategies exist on a spectrum, from non-oncology drugs to haemato-oncology drugs applied to solid tumours. The three points that the authors made against drug repurposing were off-target and require a response. Drug repurposing in oncologyIn a Comment by Audrey Tran and Vinay Prasad1 in The Lancet Oncology, the authors report on drugs originally approved for common indications (eg, diabetes and hypertension) that have been repurposed as potential therapies for cancer patients (eg, metformin, aspirin, and statins). Drug repurposing has gained popularity as a strategy to accelerate drug development because approved drugs have been already assessed for safety and efficacy, and therefore the risk of failure, timeframe, and overall costs from bench to bedside are considered to be lower than if a new or previously untested drug were being tested. Full-Text PDF Drug repurposing for cancer treatments: a well-intentioned, but misguided strategyEnthusiasm for drug repurposing is growing.1 A repurposed drug is typically defined as an affordable, widely available medication, often indicated for a common condition, such as hypertension, diabetes, or hyperlipidaemia, which is hypothesised to benefit patients with cancer. Common examples include statins, angiotensin-receptor blockers, metformin, aspirin, and vitamin D. Full-Text PDF Drug repurposing in oncology – Authors' replyWe define cancer drug repurposing as the testing of non-cancer drugs (eg, metformin, statins, or vitamin D) in cancer settings.1 We do not consider the definition of drug repurposing to mean taking a cancer drug that has been approved for one tumour and testing it in another (eg, testing pembrolizumab, approved for metastatic melanoma, for the treatment of lung cancer). The definition of drug repurposing is a key disagreement with the letters by Gauthier Bouche and colleagues, and Maria Frantzi and colleagues. Full-Text PDF" @default.
• W3108852904 created "2020-12-07" @default.
• W3108852904 creator A5010961409 @default.
• W3108852904 creator A5041247454 @default.
• W3108852904 creator A5082034251 @default.
• W3108852904 creator A5082406815 @default.
• W3108852904 date "2020-12-01" @default.
• W3108852904 modified "2023-09-29" @default.
• W3108852904 title "Drug repurposing in oncology" @default.
• W3108852904 cites W2176184837 @default.
• W3108852904 cites W2789816271 @default.
• W3108852904 cites W2896002881 @default.
• W3108852904 cites W3002246501 @default.
• W3108852904 cites W3082904125 @default.
• W3108852904 doi "https://doi.org/10.1016/s1470-2045(20)30561-1" @default.
• W3108852904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33271099" @default.
• W3108852904 hasPublicationYear "2020" @default.
• W3108852904 type Work @default.
• W3108852904 sameAs 3108852904 @default.
• W3108852904 citedByCount "3" @default.
• W3108852904 countsByYear W31088529042022 @default.
• W3108852904 countsByYear W31088529042023 @default.
• W3108852904 crossrefType "journal-article" @default.
• W3108852904 hasAuthorship W3108852904A5010961409 @default.
• W3108852904 hasAuthorship W3108852904A5041247454 @default.
• W3108852904 hasAuthorship W3108852904A5082034251 @default.
• W3108852904 hasAuthorship W3108852904A5082406815 @default.
• W3108852904 hasConcept C103637391 @default.
• W3108852904 hasConcept C126322002 @default.
• W3108852904 hasConcept C142724271 @default.
• W3108852904 hasConcept C143998085 @default.
• W3108852904 hasConcept C17744445 @default.
• W3108852904 hasConcept C18903297 @default.
• W3108852904 hasConcept C199539241 @default.
• W3108852904 hasConcept C204787440 @default.
• W3108852904 hasConcept C2779473830 @default.
• W3108852904 hasConcept C2780035454 @default.
• W3108852904 hasConcept C519536355 @default.
• W3108852904 hasConcept C71924100 @default.
• W3108852904 hasConcept C83867959 @default.
• W3108852904 hasConcept C86803240 @default.
• W3108852904 hasConcept C98274493 @default.
• W3108852904 hasConceptScore W3108852904C103637391 @default.
• W3108852904 hasConceptScore W3108852904C126322002 @default.
• W3108852904 hasConceptScore W3108852904C142724271 @default.
• W3108852904 hasConceptScore W3108852904C143998085 @default.
• W3108852904 hasConceptScore W3108852904C17744445 @default.
• W3108852904 hasConceptScore W3108852904C18903297 @default.
• W3108852904 hasConceptScore W3108852904C199539241 @default.
• W3108852904 hasConceptScore W3108852904C204787440 @default.
• W3108852904 hasConceptScore W3108852904C2779473830 @default.
• W3108852904 hasConceptScore W3108852904C2780035454 @default.
• W3108852904 hasConceptScore W3108852904C519536355 @default.
• W3108852904 hasConceptScore W3108852904C71924100 @default.
• W3108852904 hasConceptScore W3108852904C83867959 @default.
• W3108852904 hasConceptScore W3108852904C86803240 @default.
• W3108852904 hasConceptScore W3108852904C98274493 @default.
• W3108852904 hasIssue "12" @default.
• W3108852904 hasLocation W31088529041 @default.
• W3108852904 hasOpenAccess W3108852904 @default.
• W3108852904 hasPrimaryLocation W31088529041 @default.
• W3108852904 hasRelatedWork W3050951227 @default.
• W3108852904 hasRelatedWork W3137715854 @default.
• W3108852904 hasRelatedWork W3159848998 @default.
• W3108852904 hasRelatedWork W4205275007 @default.
• W3108852904 hasRelatedWork W4225380062 @default.
• W3108852904 hasRelatedWork W4283755545 @default.
• W3108852904 hasRelatedWork W4310838044 @default.
• W3108852904 hasRelatedWork W4320488970 @default.
• W3108852904 hasRelatedWork W4366833264 @default.
• W3108852904 hasRelatedWork W3099438243 @default.
• W3108852904 hasVolume "21" @default.
• W3108852904 isParatext "false" @default.
• W3108852904 isRetracted "false" @default.
• W3108852904 magId "3108852904" @default.
• W3108852904 workType "article" @default.